PHVS NASDAQ · Healthcare · FY 2025-12-31

Pharvaris N.V.

Back to NASDAQ
0.07.715.523.230.9ABVfair 4.16buy ≤ 1.04EPVnot valid for this companyEBVnot valid for this companyDBVnot valid for this companyprice 28.65 EUR
0.08.817.626.435.2ABVfair 4.74buy ≤ 1.18EPVnot valid for this companyEBVnot valid for this companyDBVnot valid for this companyprice 32.62 USD
ABV EPV EBV DBV fair value / share buy at or below (margin of safety applied) margin-of-safety band current price values in EURUSD
Verdict
Avoid
Buy zone
Overvalued
Archetype
Distressed/Deficit
Confidence
●○○ Low · 1/4
Price
28.64732.620 EURUSD *
Market cap
1.87B2.13B EURUSD *
P / B
6.89
P / E
—
EPS
-2.970-3.382
DPS / yield
— (0.0%)
NAV / share
4.1604.737
Graham number
—
Z'' score
5.25
Piotroski F
1 / 9
Beneish M
—
ROIC vs WACC
— vs 11.0%

* Listed in USD — the pipeline states price and all valuations in the filing currency EUR (fx 0.88 EUR/USD).

See the full orchestrator pipeline — solvency gate, lens cascade, reconciliation, archetype, decision, and confidence.

Subscribe to unlock this and every other tab for every company.

See the full ABV lens breakdown — gates, steps, and verdict.

Subscribe to unlock this and every other tab for every company.

See the full EPV lens breakdown — gates, steps, and verdict.

Subscribe to unlock this and every other tab for every company.

See the full EBV lens breakdown — gates, steps, and verdict.

Subscribe to unlock this and every other tab for every company.

See the full DBV lens breakdown — gates, steps, and verdict.

Subscribe to unlock this and every other tab for every company.